Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020473 (
hyperlipidemia
)
15,891
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hyperlipidaemia
is a characteristic feature not only of the
nephrotic syndrome
but also of chronic renal disease without the features of that syndrome. There is evidence for disordered lipid metabolism in patients with chronic renal disease. In these patients the disordered lipid metabolism, the precise cause of which is unknown, is characterised by hypertriglyceridaemia, the aetiology of which is probably multifactorial.
Hyperlipidaemia
is an important potential risk factor in the aetiology of cardiovascular disease, which may be a leading cause of death in patients undergoing long-term maintenance haemodialysis therapy.
...
PMID:Disorders of blood-lipids in renal disease. 4 91
Cardiovascular mortality and morbidity were assessed, after a mean follow-up period of 5 years, in an unselected series of 159 adults presenting with the
nephrotic syndrome
between 1972 and 1975. 60% of the deaths were attributed to terminal renal failure, and the incidence of deaths from ischaemic heart-disease (IHD) was not significantly above normal. The proportion of patients experiencing angina and intermittent claudication and the prevalence of ischaemic electrocardiographic changes did not differ significantly from those of a London control population. At follow-up, hypertension was significantly more common (p less than 0.001) in male nephrotic patients than in controls. Earlier reports of a greatly increased incidence of IHD in unselected patients with the
nephrotic syndrome
were not confirmed. Routine treatment of
hyperlipidaemia
in the
nephrotic syndrome
is not, therefore, recommended.
...
PMID:Does the nephrotic syndrome increase the risk of cardiovascular disease? 9 Jul 59
The
nephrotic syndrome
is the only hypoalbuminaemic state frequently associated with
hyperlipidaemia
. In the presence of a negative nitrogen balance,
hyperlipidaemia
is metabolically inappropriate and reflects the result of persistent breakaway from free fatty acid control. This lipid abnormality may result in the premature development of ischaemic heart disease in patients in whom it is not possible to control the primary renal abnormality. The authors suggest that future work should be directed towards thyroxine and insulin metabolism in nephrotic states.
...
PMID:Biochemical anomalies of the nephrotic syndrome. 16 35
Serum lipids and their lipoprotein fractions were measured in 16
nephrotic syndrome
patients. All component of lipids and beta-lipoprotein fractions (LDL) showed an increase in all uncomplicated patients. The increase in serum lipids were inversely proportional to the albumen level in these patients. In 3 patients, lipids and beta-lipoprotein fractions returned to near normal after treatment, the proteinuria diminished and serum albumen became normal. Most of these patients did not need any treatment for
hyperlipidemia
.
...
PMID:The causal role of hypoalbuminemia in human nephrotic hyperlipidemia. 19 Sep 98
The mechanism of
hyperlipidaemia
in the
nephrotic syndrome
has not been fully established. We propose that it results from hypoalbuminaemia due to inhibition of the reaction catalysed by lecithin cholesterol acyltransferase converting cholesterol of high density lipoproteins to cholesterol esters and to an inhibition of high density lipoprotein particle formation from very low density lipoproteins due to reduced activity of lipoprotein lipase.
...
PMID:The mechanism of hyperlipidaemia in the nephrotic syndrome. 23 35
Foam cells are occasionally encountered in renal glomeruli in cases of
nephrotic syndrome
, however, they were not described so far in renal allografts. The authors found the glomerular foam cells in a cadaveric kidney transplant which survived 7 months after transplantation in a 35-year-old man. Electron microscopy revealed the mesangial cells to be loaded with lipids in this case. The formation of the glomerular foam cells is generally referred to
hyperlipidemia
, but its cause remains obscure in the presented case.
...
PMID:Glomerular foam cells in kidney allograft. 35 22
A patient with congenital generalized lipodystrophy developed
nephrotic syndrome
with progressive renal glomerulosclerosis attributed to diabetic nephropathy. Renal transplantation was performed and the patient was discharged with normal renal function. Marked
hyperlipidemia
(17,500 mg/dl) persisted. One month later renal malfunction developed, and an open renal biopsy was performed when there was no response to antirejection therapy. Massive lipid deposition in renal tubular cells with tubular necrosis and hemorrhage was present but only minimal evidence of graft rejection. Rejection therapy was tapered and renal function stabilized. Death occurred 2 months later because of pulmonary sepsis. Patients with generalized lipodystrophy and severe
hyperlipidemia
may be at an unusually high risk for renal homograft destruction.
...
PMID:Renal transplantation in a patient with lipoatrophic diabetes. A case report. 36 May 16
The
nephrotic syndrome
may be associated with several complications caused by severe proteinuria. The consequences of severe renal protein loss are disturbances of water and electrolyte metabolism, thromboses and thromboembolic complications,
hyperlipidemia
with accelerated atherosclerosis and, finally, some other complications due to the decreased oncotic pressure and the renal loss of transport globulins and immunoglobulins. Diagnosis and treatment of these complications are important in the management of patients with
nephrotic syndrome
. In the present study, the frequency and localization of thromboses and thromboembolic complications in 11 patients with
nephrotic syndrome
are described. In addition, factors which are known to be responsible for the hypercoagulable state in
nephrotic syndrome
were evaluated and correlated to the thromboembolic complications in these patients. An important finding was that in all patients with thromboses and thromboembolic complications, the serum albumin concentrations were below 2 g/100 ml, whereas, with one exception, serum albumin levels were above 2 g/100 ml in cases without thromboembolic complications. Our results indicate that serum albumin levels may be used as an indirect parameter to assess the risk of thromboembolic complications in patients with
nephrotic syndrome
.
...
PMID:[Complications of nephrotic syndrome with special reference to thromboembolic accidents]. 37 Sep 77
We have evaluated the incidence, long term evolution and pathogenesis of posttransplant
hyperlipidaemia
(HL) in 88 transplanted patients without
nephrotic syndrome
followed for 2 to 13 years by the same staff. Incidence of HL decreased strikingly over the years from 51% at 2 years to 25% at 10 years. This fall was due solely to the return to normal of the lipid profile in 13 patients between 2 and 8 years after transplantation. This progressive decrease should be taken into account when the frequency of posttransplantation dyslipaemia is assessed. The incidence of
hyperlipidaemia
increases with age. Above 40 years,
hyperlipidaemia
is more frequent in females than in males. Obesity and reduced renal function are both associated with a higher incidence of dyslipaemia. No relationship was found between lipid disorders and either steroid dosage or fasting blood glucose levels. Dyslipaemia appears thus to be due to the interplay of several factors. Normalisation of the lipid profile occurred in 13 patients without significant decrease in bodyweight, serum creatinine or prednisone dosage. At 8 years atheromatous lesions were not more frequent in dyslipaemic than in normolipaemic subjects.
...
PMID:The evolution of hyperlipidaemia late after renal transplantation. 39 4
The
nephrotic syndrome
is characterized by gross proteinuria, hypoproteinemia,
hyperlipemia
, and edema. The authors review the diagnostic features and management protocol of this syndrome in children.
...
PMID:Nephrotic syndrome in childhood: diagnosis and management. 41 35
1
2
3
4
5
6
7
8
9
10
Next >>